STOCK TITAN

CEO-linked entity sells 532K Slide Insurance (SLDE) shares under 10b5-1 plan

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Slide Insurance Holdings, Inc. director and CEO Bruce Lucas reported indirect open-market sales of 532,437 shares of common stock from entities he is associated with. IIM Holdings II, LLC sold 172,644 shares on March 5 at $19.37, 241,493 shares on March 6 at $18.59, and 118,300 shares on March 9 at $18.23, all under a Rule 10b5-1 trading plan adopted on November 21, 2025. Footnotes state these LLC-held shares, spouse holdings, and family trusts are beneficially owned indirectly, with Lucas disclaiming beneficial ownership beyond his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Lucas Bruce
Role Chief Executive Officer
Sold 532,437 shs ($9.99M)
Type Security Shares Price Value
Sale Common Stock 118,300 $18.23 $2.16M
Sale Common Stock 241,493 $18.59 $4.49M
Sale Common Stock 172,644 $19.37 $3.34M
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 39,342,563 shares (Indirect, By IIM Holdings II, LLC); Common Stock — 1,123,646 shares (Direct)
Footnotes (1)
  1. Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $19.11 to $19.67 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Persondisclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.31 to $19.23 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $17.65 to $18.54 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 52,659 shares of common stock between March 5-9, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $17.65 to $19.67 per share. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did SLDE report for Bruce Lucas?

Slide Insurance reported that entities associated with CEO Bruce Lucas sold common stock. IIM Holdings II, LLC executed open-market sales totaling 532,437 shares between March 5 and March 9, 2026, under a pre-established Rule 10b5-1 trading plan adopted in November 2025.

How many Slide Insurance (SLDE) shares were sold in the latest Form 4?

The Form 4 shows indirect open-market sales totaling 532,437 shares of Slide Insurance common stock. These sales were made by IIM Holdings II, LLC, an entity controlled by Bruce Lucas, with the reporting person disclaiming beneficial ownership beyond his pecuniary interest.

At what prices were SLDE shares sold in the reported transactions?

The indirect sales occurred at weighted average prices of $19.37 on March 5, $18.59 on March 6, and $18.23 on March 9, 2026. Footnotes indicate individual trade prices ranged from $17.65 to $19.67 per share during this trading period.

Were the SLDE insider sales under a Rule 10b5-1 trading plan?

Yes. The filing states the sales were made under a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2025. Such plans pre-schedule trades, allowing insiders to sell shares according to predetermined instructions over time.

How are spouse and family trust holdings in SLDE treated in this Form 4?

The Form 4 identifies SLDE shares held by the reporting person’s spouse, Securus Risk Management LLC, and family trusts. The reporting person disclaims beneficial ownership of these securities except for any pecuniary interest, despite reporting them due to indirect relationships.

Did the SLDE Form 4 mention additional sales by the CEO’s spouse?

Yes. A footnote explains the spouse held shares after selling 52,659 shares of Slide Insurance common stock between March 5 and March 9, 2026. Those sales were also executed under a Rule 10b5-1 trading plan, at prices ranging from $17.65 to $19.67 per share.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lucas Bruce

(Last) (First) (Middle)
C/O SLIDE INSURANCE HOLDINGS, INC.
4221 W. BOY SCOUT BLVD., SUITE 200

(Street)
TAMPA FL 33607

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/05/2026 S 172,644(1) D $19.37(2) 39,702,356 I By IIM Holdings II, LLC(3)
Common Stock 03/06/2026 S 241,493(1) D $18.59(4) 39,460,863 I By IIM Holdings II, LLC(3)
Common Stock 03/09/2026 S 118,300(1) D $18.23(5) 39,342,563 I By IIM Holdings II, LLC(3)
Common Stock 1,123,646 D
Common Stock 2,575,837 I By Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014
Common Stock 194,201 I By Spouse(6)
Common Stock 1,597,341(7) I By Spouse(8)
Common Stock 1,925,000 I By Emma Cloonen Irrevocable Trust(9)
Common Stock 1,925,000 I By Ava Cloonen Irrevocable Trust(10)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $19.11 to $19.67 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
3. The securities reported herein are held by IIM Holdings II, LLC, which is an entity controlled by the Reporting Person. The Reporting Persondisclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
4. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.31 to $19.23 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
5. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $17.65 to $18.54 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
6. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
7. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 52,659 shares of common stock between March 5-9, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $17.65 to $19.67 per share.
8. Represent shares of common stock beneficially owned by the Reporting Person's spouse through Securus Risk Management LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
9. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
10. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Andy Omiridis, Attorney-in-Fact for Bruce Lucas 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.